The IPV®-2C

The IPV®-2C enhances the clinical versatility of IPV® therapy by providing added control, including demand CPAP to reduce work-of-breathing (WOB) while transitioning to Flow Ventilation®, as well as independent CPAP for weaning.

Get Help Locate a Distributor

Designed specifically for hospital use and with the versatility to treat most patients, including those in the NICU, the IPV®-2C provides Lung Conditioning Therapy, either invasively or noninvasively, for patients in all hospital units. Flow Ventilation® enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron® provides a lung protective strategy and also makes the IPV®-2C compatible with conventional ventilators, preventing the need to switch between different devices. It also provides an added advantage of demand CPAP to reduce WOB while transitioning to Flow Ventilation®, as well as independent CPAP for weaning.

Patients who may benefit include those with the following conditions:
  • COPD
  • Asthma
  • Atelectasis
  • Pneumonia
  • Premature Lungs
  • Bronchitis
Pulmonary complications of:
  • Cystic Fibrosis
  • Alpha-1
  • SMA
  • ALS

Download Spec Sheet

Benefits:
  • Restores FRC
  • Reduces time in the ICU
  • Reduces oxygen need at discharge from NICU
  • Improves Oxygenation and reduces PaCO2
  • Provides better management of COPD exacerbations
  • Reduces nosocomial infection
  • Improves airway clearance
  • Lung recruitment by treating atelectasis
  • Demand CPAP
Features:
  • Portable
  • Lightweight
  • Additional control sensitivity
  • Pneumatically powered by hospital air or O2
  • Compatible with most conventional ventilators
  • Demand CPAP
  • Independent CPAP
  • Often used with Phasitron® Kit A50095-D

How Can We Help?

Do you have a clinical support question, or need more information about our respiratory products? Please contact our Customer Support Team for more information.

iconContact Us

Flow Ventilation® Products